Assertio is Restoring Lives One Story At A Time
Recent News
January 10, 2022
Assertio Holdings, Inc. to Participate in the H.C. Wainwright BioConnect Virtual ConferenceMore News
December 15, 2021
Assertio Holdings, Inc. Announces the Acquisition of Otrexup® (methotrexate) a Drug Device Combination from Antares Pharma, Inc.More News
November 12, 2021
Assertio Holdings, Inc. Announces Preliminary Court Approval of Shareholder Derivative SettlementRead More